Skip to content

Amgen AMGN EV / EBITDA

EV / EBITDA at other companies

Eli Lilly logo
Eli LillyLLY
25.9×-24.4×
Pfizer logo
PfizerPFE
12.9×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
19.5×+3.6×
Roivant Sciences logo
Roivant SciencesROIV
1.8×
Merck & Co. logo
Merck & Co.MRK
23.1×+11.7×
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
12×+0.4×

Other financials

Income statement

See full
Revenue$8.6B+5.8%
Gross profit$5.9B+13.4%
Operating income$2.7B+126%
Net income$1.8B+5.1%
EPS (diluted)$3.34+4.4%

Balance sheet

See full
Cash & equivalents$559.0M+10.0%
Total debt$57.3B-0.1%
Total equity$9.2B+48.1%
Total assets$92.5B+3.5%

Cash flow

See full
Operating cash flow$2.2B+57.4%
CapEx$712.0M+73.2%
Free cash flow$1.5B+50.7%

Valuation

See full
Market cap$184.4B+13.3%
Enterprise value$241.16B+9.9%
P/E23.6×-3.8×
P/S+0.2×

Profitability

See full
Gross margin68.3%+5.3pp
Operating margin28.4%+6.6pp
Net margin21%+3.6pp

Returns & leverage

See full
Return on equity101.3%-4.4pp
Debt / equity6.2×-3.0×
Current ratio1.3×+0.1×

Where this comes from

Calculated from Amgen’s reported figures.

Based on the most recent quarter.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amgen's EV / EBITDA?
Amgen (AMGN) reported EV / EBITDA of 15.9× in Q1 2026.
How has Amgen's EV / EBITDA changed year-over-year?
Amgen's EV / EBITDA decreased by 7.4% year-over-year, from 17.2× to 15.9×.
What is the long-term trend for Amgen's EV / EBITDA?
Over 4 years (2021 to 2025), Amgen's EV / EBITDA has grown at a 1.9% compound annual growth rate (CAGR), from 58.4× to 63×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.